169 related articles for article (PubMed ID: 35535878)
1. The uPA/uPAR system in astrocytic wound healing.
Yepes M
Neural Regen Res; 2022 Nov; 17(11):2404-2406. PubMed ID: 35535878
[TBL] [Abstract][Full Text] [Related]
2. Urokinase-type plasminogen activator-mediated crosstalk between N-cadherin and β-catenin promotes wound healing.
Diaz A; Martin-Jimenez C; Xu Y; Merino P; Woo Y; Torre E; Yepes M
J Cell Sci; 2021 Jun; 134(11):. PubMed ID: 34085693
[TBL] [Abstract][Full Text] [Related]
3. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.
Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M
J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-Type Plasminogen Activator Triggers Wingless/Int1-Independent Phosphorylation of the Low-Density Lipoprotein Receptor-Related Protein-6 in Cerebral Cortical Neurons.
Diaz A; Martin-Jimenez C; Woo Y; Merino P; Torre E; Yepes M
J Alzheimers Dis; 2022; 89(3):877-891. PubMed ID: 35964187
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-type Plasminogen Activator Induces Neurorepair in the Ischemic Brain.
Merino P; Yepes M
J Neurol Exp Neurosci; 2018; 4(2):24-29. PubMed ID: 30417161
[TBL] [Abstract][Full Text] [Related]
6. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
Moreau M; Mourah S; Dosquet C
Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of uPAR promotes urokinase translocation into the nucleus and epithelial to mesenchymal transition in neuroblastoma.
Semina EV; Rubina KA; Shmakova AA; Rysenkova KD; Klimovich PS; Aleksanrushkina NA; Sysoeva VY; Karagyaur MN; Tkachuk VA
J Cell Physiol; 2020 Sep; 235(9):6268-6286. PubMed ID: 31990070
[TBL] [Abstract][Full Text] [Related]
8. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
9. Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling.
Tarui T; Andronicos N; Czekay RP; Mazar AP; Bdeir K; Parry GC; Kuo A; Loskutoff DJ; Cines DB; Takada Y
J Biol Chem; 2003 Aug; 278(32):29863-72. PubMed ID: 12754207
[TBL] [Abstract][Full Text] [Related]
10. Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brain.
Merino P; Diaz A; Manrique LG; Cheng L; Yepes M
J Biol Chem; 2018 Jun; 293(24):9234-9247. PubMed ID: 29720403
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-type plasminogen activator (uPA) protects the tripartite synapse in the ischemic brain via ezrin-mediated formation of peripheral astrocytic processes.
Diaz A; Merino P; Manrique LG; Cheng L; Yepes M
J Cereb Blood Flow Metab; 2019 Nov; 39(11):2157-2171. PubMed ID: 29890880
[TBL] [Abstract][Full Text] [Related]
12. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.
Tarui T; Akakura N; Majumdar M; Andronicos N; Takagi J; Mazar AP; Bdeir K; Kuo A; Yarovoi SV; Cines DB; Takada Y
Thromb Haemost; 2006 Mar; 95(3):524-34. PubMed ID: 16525582
[TBL] [Abstract][Full Text] [Related]
13. Urinary-type plasminogen activator (uPA) expression and uPA receptor localization are regulated by alpha 3beta 1 integrin in oral keratinocytes.
Ghosh S; Brown R; Jones JC; Ellerbroek SM; Stack MS
J Biol Chem; 2000 Aug; 275(31):23869-76. PubMed ID: 10791952
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System.
Merino P; Diaz A; Jeanneret V; Wu F; Torre E; Cheng L; Yepes M
J Biol Chem; 2017 Feb; 292(7):2741-2753. PubMed ID: 27986809
[TBL] [Abstract][Full Text] [Related]
15. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
Yin S; Lockett J; Meng Y; Biliran H; Blouse GE; Li X; Reddy N; Zhao Z; Lin X; Anagli J; Cher ML; Sheng S
Cancer Res; 2006 Apr; 66(8):4173-81. PubMed ID: 16618739
[TBL] [Abstract][Full Text] [Related]
16. Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes.
Chavakis T; Kanse SM; Yutzy B; Lijnen HR; Preissner KT
Blood; 1998 Apr; 91(7):2305-12. PubMed ID: 9516128
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
[TBL] [Abstract][Full Text] [Related]
18. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
[TBL] [Abstract][Full Text] [Related]
19. Urokinase-dependent human vascular smooth muscle cell adhesion requires selective vitronectin phosphorylation by ectoprotein kinase CK2.
Stepanova V; Jerke U; Sagach V; Lindschau C; Dietz R; Haller H; Dumler I
J Biol Chem; 2002 Mar; 277(12):10265-72. PubMed ID: 11756447
[TBL] [Abstract][Full Text] [Related]
20. Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion.
Bonavaud S; Charrière-Bertrand C; Rey C; Leibovitch MP; Pedersen N; Frisdal E; Planus E; Blasi F; Gherardi R; Barlovatz-Meimon G
J Cell Sci; 1997 May; 110 ( Pt 9)():1083-9. PubMed ID: 9175704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]